Etidronate Disodium Tablets

This product is a bone metabolism regulator. It has a strong affinity for calcium phosphate in the body, can inhibit abnormal calcification and excessive bone absorption in the human body, relieve bone pain, reduce the concentration of serum alkaline phosphatase and urinary hydroxyproline; at low doses, it can directly inhibit osteoclast formation and prevent bone absorption, reduce bone turnover rate, increase bone density, etc. to achieve bone calcium regulation.

The main ingredient of this product is: etidronate disodium. Its chemical name is: (1-hydroxyethylidene) diphosphonic acid disodium salt.

This product is a white tablet.

Used for postmenopausal osteoporosis and aging-related osteoporosis.

Oral administration: 0.2 g at a time, twice a day, between meals.

Symptoms include abdominal discomfort, diarrhea, soft stools, vomiting, stomatitis, burning sensation in the throat, headache, itchy skin, and rash.

It is contraindicated for patients with severe renal impairment and osteomalacia.

Precautions for children: It may affect bone growth. There have been reports of rickets-like symptoms after long-term use. It should be used with caution. Precautions for pregnancy and lactation: Animal experiments have found that high doses can cause fetal bone abnormalities, and the drug can enter breast milk. Therefore, pregnant women and women who may become pregnant should not use it.

This product is a bone resorption inhibitor. At low doses, it inhibits osteoclast activity, prevents bone resorption, and reduces bone turnover rate to achieve bone calcium regulation.

Keep away from light, sealed and stored in a dry place.

0.2g

36 months

Tianjin Pacific Pharmaceutical Co., Ltd.

• Founded in:

  1994-08-08

• Address:

  Economic Development Zone, Xiqing District, Tianjin

• Tax NO.:

  91120111600584134N

• Registered Funds:

  133.19 million yuan

• Website:

  Log in to view

• Email:

  Log in to view